Person looking at computer screen

Emerging Markets Trust

  • Vehicle Australian Trust
  • Asset Class Equities

Overview

The GMO Emerging Markets Trust seeks to generate total return in excess of that of its benchmark, the S&P/IFCI CompositeMSCI Emerging Markets Index. 
The Trust is distinguished by an emphasis on both top-down country-sector allocation and value. The Emerging Markets Equity team believes that getting macroeconomic perspectives right in emerging equity markets is most important and that value wins over the long term. The team applies both quantitative and fundamental insights to evaluate countries, sectors, and stocks, using an investment process focused on value and also informed by quality and sentiment inputs. 

Facts

Doc Table
Fund Inception Date February 12, 2002
Fund Total Assets as of 8/31/2019 $63mm USD
Benchmark MSCI Emerging Markets
NAV as of 9/19/2019 1.2347

Performance

Quarter-End as of June 30, 2019(AUD, %)

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Trust 4.01 13.32 11.15 12.33 8.27 6.54 7.18
MSCI Emerging Markets 1.84 10.95 6.56 12.88 8.75 7.32 7.60
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Quarter-End as of June 30, 2019(AUD, %)

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Trust 4.28 13.90 12.32 13.53 9.46 7.75 8.45
MSCI Emerging Markets 1.84 10.95 6.56 12.88 8.75 7.32 7.60
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Month-End as of August 31, 2019(AUD, %)

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Trust -3.59 -2.60 10.37 6.23 8.85 6.88 5.43 6.95
MSCI Emerging Markets -2.69 -2.13 8.58 2.66 9.69 7.19 6.43 7.39
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Month-End as of August 31, 2019(AUD, %)

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Trust -3.50 -2.42 11.14 7.35 10.01 8.06 6.63 8.21
MSCI Emerging Markets -2.69 -2.13 8.58 2.66 9.69 7.19 6.43 7.39
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Year Ending December 31 (AUD, %)

Calendar
Emerging Markets Trust MSCI Emerging Markets
2018 -3.82 -5.10
2017 22.13 27.09
2016 16.34 11.72
2015 -6.31 -4.30
2014 1.74 6.93
2013 8.72 13.03
2012 14.27 16.74
2011 -17.45 -18.44
2010 5.34 4.30
2009 31.66 38.38
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Year Ending December 31 (AUD, %)

Calendar
Emerging Markets Trust MSCI Emerging Markets
2018 -2.80 -5.10
2017 23.40 27.09
2016 17.67 11.72
2015 -5.21 -4.30
2014 2.92 6.93
2013 9.98 13.03
2012 15.58 16.74
2011 -16.47 -18.44
2010 6.61 4.30
2009 33.26 38.38
  • Emerging Markets Trust 1 - 2
  • MSCI Emerging Markets

Inception Date: February 12, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

1 As of January 1, 2019, the Emerging Markets Trust changed its benchmark so that the Trust now seeks total return in excess of that of the MSCI Emerging Markets Index. The Trust formerly sought to outperform the S&P/IFCI Composite Index.

2 The GMO Emerging Markets Trust ARSN 089 054 446 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Management

Chiang_Warren

Warren Chiang

Head of Quantitative, Emerging Markets Equity

Mr. Chiang is a portfolio manager for GMO’s Emerging Markets Equity team and oversees quantitative research. Prior to joining GMO in 2015, he worked at Mellon Capital Management as a Managing Director of Active Equity Strategies. Previously, he worked at the Federal Reserve Bank of San Francisco as a research associate. Mr. Chiang earned his B.A. in Economics and his MBA from the University of California Berkeley. He is a CFA charterholder.

Bhartia_Amit

Amit Bhartia

Head of Fundamental, Emerging Markets Equity

Mr. Bhartia is a portfolio manager for GMO’s Emerging Markets Equity team and oversees fundamental research. Additionally, he serves as CEO and an executive director of GMO Singapore Pte Ltd. Prior to joining GMO in 1995, he worked as an investment advisor in India. Mr. Bhartia earned a Bachelor of Engineering at the University of Bombay and an MBA at the Institute for Technology and Management in Bombay. He is a CFA charterholder.

Divecha_Arjun

Arjun Divecha

Head of Emerging Markets Equity

Mr. Divecha is the head of GMO’s Emerging Markets Equity team and a member of the GMO Board of Directors. Prior to joining GMO in 1993, he spent 12 years at BARRA directing software development, marketing, client service and emerging markets research and development. Mr. Divecha holds a Bachelor of Technology in Aeronautical Engineering from the Indian Institute of Technology, Bombay and an M.B.A. in Finance from Cornell University.

Documents

Literature

Fact Sheet
Information Memorandum for Wholesale Investors
Product Disclosure Statements for Non-Wholesale Investors
Statement of Additional Information
Download All

Downloads

Performance
Portfolio Composition
Holdings
Download All

Commentary & Attribution

Commentary - Monthly
Commentary - Quarterly
Attribution - Monthly
Attribution - Quarterly
Attribution - YTD
Download All

Investor Information

Annual Report
NAVs and Distributions
Distribution Estimates
Distribution Estimates - 14 Feb 2012
Distribution Estimates - 28 June 2019
Distribution Estimates - 29 Dec 2017
Distribution Estimates - 29 Jun 2018
Distribution Estimates - 29 Sep 2017
Distribution Estimates - 30 Dec 2016
Distribution Estimates - 30 Jun 2015
Distribution Estimates - 30 Jun 2016
Distribution Estimates - 30 Jun 2017
Distribution Estimates - 30 Sep 2015
Distribution Estimates - 31 Dec 2015
Distribution Estimates - 31 Jan 2013
Download All

Risks

Risks associated with an investment in the Trust may include Market Risk - Equity Securities, Small Company Risk, Currency Risk, Derivatives and Short Sales Risk, and Foreign Investment Risk. For a more complete discussion of these risks and others, please consult the Trusts Product Disclosure Statement.

Disclosures

The GMO Australia Trusts (the "Trusts") are issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656. The Trusts accept investments from wholesale investors only. Retail investors are not able to directly invest in the Trusts but may be able to gain exposure to some of the Trusts by investing with certain investor directed portfolio services, master trusts, wrap accounts or custodians ("Services"). GMO Australia Limited, GMO LLC, and their affiliates, do not guarantee the performance of any Trust or the repayment of an investor's capital.

This information is of a general nature only and is not advice. It does not take into account the objectives, financial situation or needs of any specific investor. The offer to invest in a Trust for wholesale investors is contained in the current Information Memorandum. A Product Disclosure Statement ("PDS") may be available for some of the Trusts and is solely for use by retail investors gaining exposure to a Trust through a Service. The Information Memorandum and PDS (if available) may be accessed from this website. Investors should read the Information Memorandum or PDS, consider their own circumstances, and obtain their own advice before making an investment decision.

Back to top